Reckitt Benckiser, maker of Nurofen painkillers and Durex condoms, is in advanced talks to acquire Mead Johnson in a deal that could value the US baby-milk group at about $16.7bn.
Reckitt said it had offered to pay $90 a share in cash for Mead, a near-30 per cent premium on its closing shar
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
